Lanean...
Targeting HAUSP in both p53 wildtype and p53-mutant tumors
Inhibition of Mdm2 function is a validated approach to restore p53 activity for cancer therapy; nevertheless, inhibitors of Mdm2 such as Nutlin-3 have certain limitations, suggesting that additional targets in this pathway need to be further elucidated. Our finding that the Herpesvirus-Associated Ub...
Gorde:
| Argitaratua izan da: | Cell Cycle |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6056219/ https://ncbi.nlm.nih.gov/pubmed/29616860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2018.1456293 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|